罗哌卡因复合舒芬太尼用于剖宫产术后镇痛的临床观察

Clinical Study on Ropivacaine and Sufentanil for Postoperative Analgesia of Cesarean Section

目的:探讨罗哌卡因复合舒芬太尼用于剖宫产术后镇痛疗效。方法:回顾性分析2009年3月—2010年8月间120例分别采用罗哌卡因200mg(2.5g/L)+舒芬太尼0.04mg+地塞米松5mg和罗哌卡因200mg(2.5g/L)+芬太尼0.4mg(4mg/L)+地塞米松5mg镇痛的剖宫产患者的临床资料。结果:观察组60例产妇6h、12h、24h、48hVAS评分明显高于对照组(P<0.01);优良率比较差异有统计学意义(P<0.05)。结论:罗哌卡因复合舒芬太尼适合剖宫产术后产妇的镇痛,无严重不良反应。

Objective： To explore the effect of ropivaeaine with sufentanil for postoperative analgesia of cesarean section. Methods： The analgesia data of 120 patients undergoing cesarean section which were taken ropivacaine 200mg（2.5g/L）, sufentanil 0.04rag, dexamethasone 5mg and ropivacaine 200mg（2.5g/L）, fentanyl 0.4mg（4mg/L）, dexamethasone 5rag were analyzed retrospectively from Mar. 2009 to Aug. 2010. Results：The VAS scores with 6h, 12h,24h,48h for 60 parturients in observation group was signifi- cantly higher than those in control group （P〈0.01） ; The differenes had statistical significance with comparison of excellent rate （x2 4.39, P〈0.05）. Conchlsion ： ropivacaine with sufentanil were suitable for parturient with postoperative analgesia of cesarean sec- tion without adverse reactions.